Author:
Wang Wenwu,Ouyang Xuenong
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Krajnik G, Mohn-Staudner A, Thaler J, et al. Vinorelbine-gemcitabine in advance non-small cell lung cancer (NSCLC): an AASLC Phase II trial. Austrian Association for the Study of Lung Cancer. Ann Oncol, 2000, 11: 993–998.
2. Ren ZH, Zhang CH, Li M. The clinical observation of combined chemotherapy of irinotecan and cisplatin in the treatment of relapsed advanced small cell lung cancer. Chinese-German J Clin Oncol, 2008, 7: 506–508.
3. Frasci G, Lorusso V, Panza N, et al. Gemcitabine plus Vinorelbine versus Vinorelbine alone in elderly patients with advanced non-small cell lung cancer. J Clin Oncol, 2000, 18: 2529–2536.
4. Gridelli C, Perrone F, Cigolar S, et al. The MILES (Multicenter Italian Lung Cancer in the Elderly Study) phase III trial: gemcitabine + Vinorelbine vs vinorelbine and vs gemcitabine in elderly advanced NSCLC patients [abstract 1230]. Proc Am Soc Clin Oncol, 2001, 20: 308 a.
5. Greco FA, Gray JR Jr, Thompson DS, et al. Prospective randomized study of four novel chemotherapy regimens in patients with advanced non-small cell lung carcinoma. Cancer, 2002, 95: 1279–1285.